Tackling Dialysis Burden around the World: A Global Challenge
- PMID: 34179112
- PMCID: PMC8215964
- DOI: 10.1159/000515541
Tackling Dialysis Burden around the World: A Global Challenge
Abstract
CKD is a global problem that causes significant burden to the healthcare system and the economy in addition to its impact on morbidity and mortality of patients. Around the world, in both developing and developed economies, the nephrologists and governments face the challenges of the need to provide a quality and cost-effective kidney replacement therapy for CKD patients when their kidneys fail. In December 2019, the 3rd International Congress of Chinese Nephrologists was held in Nanjing, China, and in the meeting, a symposium and roundtable discussion on how to deal with this CKD burden was held with opinion leaders from countries and regions around the world, including Australia, Canada, China, Hong Kong, Singapore, Taiwan, the UK, and the USA. The participants concluded that an integrated approach with early detection of CKD, prompt treatment to slow down progression, promotion of home-based dialysis therapy like peritoneal dialysis and home HD, together with promotion of kidney transplantation, are possible effective ways to combat this ongoing worldwide challenge.
Keywords: Chronic kidney disease; End-stage kidney disease; Home dialysis; Kidney transplantation; Prevention.
Copyright © 2021 by S. Karger AG, Basel.
Conflict of interest statement
P.K.T.L. received speaker honorarium from FibroGen and AstraZeneca. W.H.L. received speaker honorarium from Alexion and Astellas and an education grant from Novartis. B.W.T. received honoraria, consulting or speaker fees, or travel support from Böhringer Ingelheim, Novartis, Astellas, Sanofi, Servier, M.S.D., Astra-Zeneca, and Otsuka. X.Q.Y. received research study supports from Baxter Healthcare Corporation, Wanbang company, Kyowa-Kirin, and AstraZeneca. G.S.K. and X.Q.Y. also acted as consultants for Fresenius Kabi, Baxter Healthcare Corporation, and AstraZeneca. Z.H.L. and J.C.H. are working as editor-in-chief and associate editor, respectively, for Kidney Diseases, and P.K.T.L., J.H.C., and X.Q.Y. are editorial board members for Kidney Diseases.
Figures



Similar articles
-
Addressing the burden of dialysis around the world: A summary of the roundtable discussion on dialysis economics at the First International Congress of Chinese Nephrologists 2015.Nephrology (Carlton). 2017 Dec;22 Suppl 4:3-8. doi: 10.1111/nep.13143. Nephrology (Carlton). 2017. PMID: 29155495 Review.
-
Navigating the Global Economic Landscape of Dialysis: A Summary of Expert Opinions from The 4th International Congress of Chinese Nephrologists.Kidney Dis (Basel). 2024 Jul 24;10(5):384-397. doi: 10.1159/000540152. eCollection 2024 Oct. Kidney Dis (Basel). 2024. PMID: 39430291 Free PMC article. Review.
-
Peritoneal dialysis first policy in Hong Kong for 35 years: Global impact.Nephrology (Carlton). 2022 Oct;27(10):787-794. doi: 10.1111/nep.14042. Epub 2022 Apr 13. Nephrology (Carlton). 2022. PMID: 35393750 Free PMC article. Review.
-
Peritoneal Dialysis in Asia.Kidney Dis (Basel). 2015 Dec;1(3):147-56. doi: 10.1159/000439193. Epub 2015 Sep 11. Kidney Dis (Basel). 2015. PMID: 27536675 Free PMC article. Review.
-
2018 Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C in Chronic Kidney Disease Guideline Implementation: Asia Summit Conference Report.Kidney Int Rep. 2020 May 21;5(8):1129-1138. doi: 10.1016/j.ekir.2020.05.001. eCollection 2020 Aug. Kidney Int Rep. 2020. PMID: 32775812 Free PMC article.
Cited by
-
Sexual Effect of Platelet-to-Lymphocyte Ratio in Predicting Cardiovascular Mortality of Peritoneal Dialysis Patients.Mediators Inflamm. 2022 Jan 4;2022:8760615. doi: 10.1155/2022/8760615. eCollection 2022. Mediators Inflamm. 2022. PMID: 35027865 Free PMC article.
-
The Relationship Between Palliative Care Needs and Spiritual Well-being of Maintenance Hemodialysis Individuals in China: A Cross-Sectional Study.J Relig Health. 2025 Jun;64(3):2321-2336. doi: 10.1007/s10943-025-02326-2. Epub 2025 May 27. J Relig Health. 2025. PMID: 40423760
-
Risk of COVID-19 and Cost Burden in End-Stage Renal Disease Patients and Policy Implications for Managing Nephrology Services during the COVID-19 Pandemic.Healthcare (Basel). 2022 Nov 23;10(12):2351. doi: 10.3390/healthcare10122351. Healthcare (Basel). 2022. PMID: 36553874 Free PMC article.
-
Analysis of the trajectory of cognitive function changes and influencing factors in maintenance hemodialysis patients: a prospective longitudinal study.Ren Fail. 2025 Dec;47(1):2489722. doi: 10.1080/0886022X.2025.2489722. Epub 2025 Apr 14. Ren Fail. 2025. PMID: 40230078 Free PMC article.
-
Worldwide hotspots and trends in stem cell therapy for kidney disease in the last decade: a bibliometric and visualization analysis from 2015 to 2024.Front Immunol. 2025 Jul 21;16:1619291. doi: 10.3389/fimmu.2025.1619291. eCollection 2025. Front Immunol. 2025. PMID: 40761782 Free PMC article.
References
-
- International Society of Nephrology 2019 United Nations high level meeting on UHC: moving together to build kidney health worldwide. 2019. Retrieved 20 July 2019 https://www.theisn.org/images/Advocacy_4_pager_2019_Final_WEB_pagebypage....
-
- Li PK, Garcia-Garcia G, Lui SF, Andreoli S, Fung WW, Hradsky A, et al. Kidney health for everyone everywhere-from prevention to detection and equitable access to care. Kidney Int. 2020 Feb;97((2)):226–32. - PubMed
-
- Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet. 2018;392((10159)):2052–90. - PMC - PubMed
-
- Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385((9981)):1975–82. - PubMed
-
- Vanholder R, Annemans L, Brown E, Gansevoort R, Gout-Zwart JJ, Lameire N, et al. Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nat Rev Nephrol. 2017;13((7)):393–409. - PubMed
LinkOut - more resources
Full Text Sources